Aridis Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2018 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aridis Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2018 to Q3 2023.
  • Aridis Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 30, 2023 was 44.6M shares, a 114% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 44.6M +23.8M +114% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 36.1M +18.4M +104% Jun 30, 2023 10-Q 2023-09-14
Q1 2023 36.1M +18.4M +104% Apr 30, 2023 10-K 2023-05-22
Q3 2022 20.8M +6.75M +48% Oct 31, 2022 10-Q 2022-11-21
Q2 2022 17.7M +5.58M +46.1% Jul 29, 2022 10-Q 2022-08-16
Q1 2022 17.7M +6.47M +57.7% Apr 11, 2022 10-K 2022-04-13
Q3 2021 14.1M +3.99M +39.6% Oct 31, 2021 10-Q 2021-11-10
Q2 2021 12.1M +3.2M +35.8% Jul 31, 2021 10-Q 2021-08-12
Q1 2021 11.2M +2.31M +25.9% Mar 24, 2021 10-K 2021-03-30
Q3 2020 10.1M +1.15M +12.9% Oct 31, 2020 10-Q 2020-11-23
Q2 2020 8.92M +11.1K +0.13% Jul 31, 2020 10-Q 2020-08-11
Q1 2020 8.92M +813K +10% Mar 16, 2020 10-K 2020-04-08
Q3 2019 8.91M +808K +9.98% Oct 31, 2019 10-Q 2019-11-13
Q2 2019 8.91M Jul 31, 2019 10-Q 2019-08-12
Q1 2019 8.11M Mar 26, 2019 10-K 2019-03-28
Q3 2018 8.1M Sep 25, 2018 10-Q 2018-09-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.